Thomas M. Habermann
8 Podcast Episodes
Panel Discussion: Marginal Zone Lymphoma - Thomas M. Habermann, MD and John P. Leonard, MD
Panel Discussion: Marginal Zone Lymphoma - Thomas M. Habermann, MD and John P. Leonard, MD
Treatment for Marginal Zone Lymphoma: Should it be Different from FL?
31 Dec 2019
•
1min
Panel Discussion on 'Great' Debates in Follicular Lymphoma - John P. Leonard, MD; Carla Casulo, MD; Bruce D. Cheson, MD; Richard I. Fisher, MD; Thomas M. Habermann, MD; Peter Martin, MD
Panel Discussion on 'Great' Debates in Follicular Lymphoma - John P. Leonard, MD; Carla Casulo, MD; Bruce D. Cheson, MD; Richard I. Fisher, MD; Thomas M. Habermann, MD; Peter Martin, MD
Moving Forward in the Treatment of Relapsed/Refractory Follicular Lymphoma: Understanding the PI3K Inhibitors
31 Dec 2019
•
8mins
Similar People
Sonia Friedman
Robert Sidbury
Jonathan Kay
Richard Kim
Stanley Cohen
Matt S
Atopic Dermatitis
Axel Grothey
Tanios Bekaii-Saab
Ghassan Abou-Alfa
Heinz-Josef Lenz
Rakesh Jain
Josep Tabernero
Jean-Yves Douillard
John Cooper
Panel Discussion: 'Great' Debates in Follicular Lymphoma - John P. Leonard, MD; Carla Casulo, MD; Bruce D. Cheson, MD; Richard I. Fisher, MD; Thomas M. Habermann, MD; Peter Martin, MD
Panel Discussion: 'Great' Debates in Follicular Lymphoma - John P. Leonard, MD; Carla Casulo, MD; Bruce D. Cheson, MD; Richard I. Fisher, MD; Thomas M. Habermann, MD; Peter Martin, MD
Moving Forward in the Treatment of Relapsed/Refractory Follicular Lymphoma
31 Dec 2019
•
8mins
Treatment for Marginal Zone Lymphoma: Should it be Different from Follicular Lymphoma? - Thomas M. Habermann, MD
Treatment for Marginal Zone Lymphoma: Should it be Different from Follicular Lymphoma? - Thomas M. Habermann, MD
Treatment for Marginal Zone Lymphoma: Should it be Different from FL?
31 Dec 2019
•
19mins
Most Popular
Elon Musk
Barack Obama
Bill Gates
LeBron James
Mark Cuban
Michelle Obama
Melinda Gates
Arnold Schwarzenegger
Kevin Hart
Terry Crews
Mike Tyson
Panel Discussion: Marginal Zone Lymphoma - Thomas M. Habermann, MD and John P. Leonard, MD
Panel Discussion: Marginal Zone Lymphoma - Thomas M. Habermann, MD and John P. Leonard, MD
Treatment for Marginal Zone Lymphoma: Should it be Different from FL?
31 Dec 2019
•
1min
Treatment for Marginal Zone Lymphoma: Should it be Different from Follicular Lymphoma? - Thomas M. Habermann, MD
Treatment for Marginal Zone Lymphoma: Should it be Different from Follicular Lymphoma? - Thomas M. Habermann, MD
Treatment for Marginal Zone Lymphoma: Should it be Different from FL?
31 Dec 2019
•
19mins
Panel Discussion: 'Great' Debates in Follicular Lymphoma - John P. Leonard, MD; Carla Casulo, MD; Bruce D. Cheson, MD; Richard I. Fisher, MD; Thomas M. Habermann, MD; Peter Martin, MD
Panel Discussion: 'Great' Debates in Follicular Lymphoma - John P. Leonard, MD; Carla Casulo, MD; Bruce D. Cheson, MD; Richard I. Fisher, MD; Thomas M. Habermann, MD; Peter Martin, MD
Moving Forward in the Treatment of Relapsed/Refractory Follicular Lymphoma
31 Dec 2019
•
8mins
Panel Discussion on 'Great' Debates in Follicular Lymphoma - John P. Leonard, MD; Carla Casulo, MD; Bruce D. Cheson, MD; Richard I. Fisher, MD; Thomas M. Habermann, MD; Peter Martin, MD
Panel Discussion on 'Great' Debates in Follicular Lymphoma - John P. Leonard, MD; Carla Casulo, MD; Bruce D. Cheson, MD; Richard I. Fisher, MD; Thomas M. Habermann, MD; Peter Martin, MD
Moving Forward in the Treatment of Relapsed/Refractory Follicular Lymphoma: Understanding the PI3K Inhibitors
31 Dec 2019
•
8mins
